key: cord-0026933-llsd995l
authors: Hart, Alexander; Goffredo, Paolo; Carroll, Rory; Lehmann, Ryan; Nau, Peter; Smith, Jessica; Ahad, Sajida; Bao, Wei; Hassan, Imran
title: Optimizing Bariatric Surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures
date: 2020-08-12
journal: Surg Endosc
DOI: 10.1007/s00464-020-07887-9
sha: 444ae0af9f85762a9d6e1191f223afb4a6b008fd
doc_id: 26933
cord_uid: llsd995l

INTRODUCTION: The use of bariatric surgery in the management of obesity and its related morbidity has significantly increased in the US over the past decade. There is a lack of data on the impact of optimal preoperative glycemic control on the morbidity and mortality following bariatric surgery. The aim of this study was to analyze the impact of hemoglobin (Hb) A1c > 7 on outcomes among patients undergoing Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG). METHODS: Data were extracted from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (2017) and limited to patients undergoing an elective laparoscopic RYGB or SG. Multivariable logistic regression was conducted to adjust for other preoperative variables. RESULTS: A total number of 31,060 (69.3%) patients underwent SG, while 13,754 (30.7%) received RYGB. Patients who were older, male, non-Hispanic, smokers, and those with a higher American Society of Anesthesiologist Classification (ASA) score were more likely to have elevated HbA1c levels. Compared to individuals with normal HbA1c levels, patients with elevated levels had no significant difference in mortality (p = 0.902) but did have a difference in composite morbidity and mortality (p < 0.001). On multivariable analysis, elevated HbA1c, older age, increasing body mass index (BMI), elevated creatinine, longer operations, African American race, receiving RYGB, and having a trainee as surgical assistant were found to increase the odds of having an adverse outcome. No significant difference was found within smoking status, sex, ASA Classification, robotic vs laparoscopic, or if a second attending surgeon was assisting. CONCLUSIONS: HbA1c levels and presence of trainees in the OR are modifiable preoperative risk factors for adverse events following bariatric surgery. Improving preoperative glycemic control may be an effective and achievable quality improvement measure.

obesity and related conditions [1] [2] [3] [4] . The indications for bariatric procedures include a Body Mass Index (BMI) > 40 kg/m 2 , or having a BMI > 35 kg/m 2 with an obesityrelated comorbidity, including diabetes. Overall, ~ 25% of morbidly obese patients will develop diabetes compared to 8.9% of the general population [5] . As a consequence, the obese subpopulation has an increased prevalence of elevated hemoglobin (Hb) A1c values [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] .

Higher preoperative HbA1c levels are known to increase postoperative morbidity in a variety of surgical patient cohorts [17, 18] . Aminian et al. developed a validated risk calculator tool utilizing a cohort of 659 patients from a single institution, where controlled preoperative HbA1c was found to be a significant predictor of postoperative glycemic and Other Interventional Techniques Alexander Hart and Paolo Goffredo have contributed equally to this work.

control [18] . This association between preoperative HbA1c and postoperative glycemic control was also noted in a retrospective chart review of 468 bariatric surgery patient by Perna et al. [19] This study found elevated preoperative HbA1c to be associated with lower rates of diabetic remissions and weight loss. However, there is a scarcity of data on the impact of achieving good preoperative glycemic control on postoperative outcomes following bariatric surgery.

The current study aimed to analyze the association between preoperative HbA1c levels and 30 day postoperative complications following bariatric surgery utilizing the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Database. We hypothesized that elevated preoperative HbA1c levels (> 7) prior to bariatric surgery would be associated with worse postoperative outcomes.

The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Participant Use Data File (MBSAQIP PUF) was analyzed for the year 2017. This data file is Health Insurance Portability and Accountability Act Compliant covering 780 accredited bariatric surgery programs in the United States and Canada, and accounts for 94% of all bariatric surgeries in these countries. Data entry is performed by trained metabolic and bariatric surgical clinical reviewers via patient medical record review [20] .

This study included all patients with documented preoperative HbA1c levels who underwent a standard laparoscopic or robotic Sleeve Gastrectomy (SG) or Roux-en-Y Bypass (RYGB) (Current Procedural Terminology codes 43775, 43644, and 43645). Sixty-six percent of the patients did not have a recorded preoperative HbA1c level and were thus excluded from the analyses. Patients who had emergent, revision, open, or converted to open surgeries were excluded. Patients were also excluded if they had a history of previous midgut surgery or if they had secondary Current Procedural Terminology (CPT) codes associated with the treatment of comorbid conditions which would affect postoperative outcomes. Hemoglobin A1c levels > 7 were defined as elevated. All patients had A1c levels checked prior to the surgical intervention.

Complication data was collected from the MBSAQIP. This study utilizes a composite Death and Serious Morbidity outcome, which included 30-day mortality, ventilator requirement after 48 h, an unplanned intubation, pneumonia, superficial surgical site infection, deep surgical site infection, organ space surgical site infection, pulmonary embolism, a reintervention within 30 days, myocardial infarction, sepsis, septic shock, cerebrovascular accident, cardiac arrest requiring cardio pulmonary resuscitation, progressive renal insufficiency, or vein thrombosis requiring treatment [21] [22] [23] . The composite outcome represented the summation of the counts of all listed adverse events. This decision was driven by the relatively low number of each individual complication.

Univariately continuous variables were compared using 2-sided t-tests, and categorical variables were compared using chi-squared analysis. Multivariate logistic regression was conducted utilizing the composite outcome member. All tests were two sided and a p value < 0.05 was set for significance. P values with > 4 decimals were rounded up to < 0.001. This work was deemed to be IRB exempt and did not qualify as human subject research. Analyses were conducted in SAS version 9.4 (SAS Institute, Cary, NC) 8.3.5.

A total of 44,814 patients met inclusion criteria: 69.3% patients underwent SG, while 30.7% had RYGB. The cohort included primarily females (77.6%) and Caucasians (72.6%). Mean BMI was 45.6 kg/m 2 .

The mean age in the elevated HbA1c cohort was 47.7 years as compared to 43.6 years in the normal level population (Table 1) . Gender differed significantly between the two groups with the elevated group being having a higher proportion of females compared to the normal group (71.1% vs 79.6%, p < 0.001). Also, positive smoking status was significantly higher in the elevated HbA1c group being 8.7% of the cohort versus 8.0% in the normal group (p = 0.032). Additionally, mean BMI was lower in the elevated HbA1c group at (45.0 kg/m 2 vs 45.8 kg/m 2 , p < 0.001). Patients in the elevated HbA1c group underwent SG less frequently than the normal cohort (61.7% vs 71.7%, p < 0.001). The elevated HbA1c group had a higher proportion of patients with ASA ≥ 3 as compared to the normal HbA1c group (85.8% vs 78.2%, p < 0.001).

In univariate analysis, postoperative outcomes of patients with elevated HbA1c levels were compared to those of the normal HbA1c group (Table 2) . Although there was no difference in mortality, significantly higher rates of composite morbidity and mortality were observed in the elevated HbA1c group (p < 0.001).

On multivariable analysis, elevated HbA1c was found to have significantly increased odds of having an adverse postoperative outcome (odds ratio = 1.2, 95% CI 1.03-1.37). Older age, BMI, elevated creatinine, longer operations, African American race, and undergoing a RYGB were all independently associated with higher postoperative morbidity rates (all p < 0.001). As compared to having a nurse practitioner or physician assistant as lead assistant, there was no increased rates of complications when the case was performed by two attending physicians. However, procedures for which there was no assistant, a resident, or a fellow as the lead assist all had significant increased odds ratios of 1.4 (95% CI 1.13-1.68), 1.3 (95% CI 1.06-1.52), and 1.4 (95% CI 1.10-1.66), respectively (Fig. 1) . In a subset analysis comparing non-trainee assistants vs residents and fellows, the former group had a significantly lower reoperation rate (1.0% vs 1.4%, p = 0.030) and decreased operating time (75 ± 43 vs 102 ± 51 minutes, p < 0.001). No significant difference was found within smoking status, sex, ASA Classification, or robotic vs laparoscopic surgical approach.

This study utilized a large nationally representative database to evaluate the impact of HbA1c on short-term outcomes after bariatric surgery. Our data suggest a positive association between elevated HbA1c levels and the odds of developing postoperative complications. Moreover, the presence of trainees in the OR and undergoing RYGB were independently associated with adverse outcomes.

Our findings support the hypothesis that elevated HbA1c levels are associated with adverse outcomes following bariatric surgery. This observation is in contrast with the conclusion of Rawlins et al. Those authors published a retrospective study of 342 patients undergoing a RYGB and found that elevated preoperative HbA1c did not increase complication rates [24] . This difference may be explained by two main reasons: 1. the sample size was much smaller so the study had lower statistical power; 2. all 342 patients were treated with medications for glycemic control, which could lessen the effects of elevated HbA1c levels. Other fields have also identified preoperative HbA1c as a risk factor for postoperative morbidity. In posterior thoracic and lumbar spinal surgery, Hikata et al. found elevated HbA1c to be associated with increased rates of surgical site infection [25] . Gustafsson et al., in the field of colorectal surgery, found among 120 prospectively followed patients that elevated preoperative HbA1c was predictive of poor postoperative glycemic control and increased postoperative complication rates [26] . Additionally, Underwood et al. reported that elevated HbA1c was associated with poor surgical outcomes, such as longer length of stay, following non cardiac procedures on diabetics [27] . Moreover, following coronary artery bypass grafting, an elevated HbA1c level was identified to significantly increase the odds of mortality, myocardial infarction, and deep sternal wound infection [28] . Interestingly, being in an elevated ASA category did not increase the risk of postoperative complications in this study. Elevated HbA1c is included in calculating ASA category, indicating that this measure alone could be a more valuable indicator of postoperative risk compared to the composite preoperative measure. Therefore, given the elective setting of bariatric surgery, efforts should be made to control preoperative hyperglycemia to decrease the rate of short-term complications.

It was found that having no assist, a surgical resident, or a minimally invasive surgical fellow was associated with worse outcomes, as compared to having any attending surgeon as the lead assist. This is consistent with a study utilizing MBSAQIP by Bonner et al., which showed that having a trainee surgeon as assistant was significantly associated with adverse postoperative outcomes in [29] . In addition, Aminian et al. found in the standard NSQIP that fellows involved with Rouxen-Y bypass had increased odds of surgical complications and reoperation as compared to surgeries with no trainees involved [30] . Hsu et al. in a single institution study found similar results; lower assistant training levels were significantly associated with longer operative times and increased blood loss, as well as higher intraoperative complication and re-admission rates, intensive care unit admissions, or length of stay [31] . On the other hand, the results published by Oliak et al. and others showed that fellowship trained bariatric surgeons had shorter intraoperative time, lower rates of major complications, and decreased mortality [32] [33] [34] . These results indicate that further work should be done to implement new teaching models.in the training of bariatric surgeons to balance the complications of future versus current patients. This study had several limitations, including those inherent to large datasets (ie coding errors). Although a composite outcome may limit the clinical interpretation of the results, this score was utilized for two primary reasons: (1) limited sample size of each individual outcome; and (2) wide range of systemic effects of elevated HbA1c levels. The goal was to capture this effect by combining a large variety of outcomes. However, due to differential frequencies of some adverse outcomes, there could be uneven representation of specific complications in the composite morbidity measure. Additionally, two thirds of the initial cohort were excluded due to missing HbA1c levels, which could have potentially introduced a bias in our analyses. This should be at least in part mitigated by the large sample size and the generally nationally representative nature of the MBSASQIP dataset. Another limitation was the ability to only measure information available in the database. Variables not included in the data set such as socio-economic or insurance status, current or previous medical management of diabetes, or center volume may have effects on surgical outcomes. Lastly, the MBSAQIP PUF only includes 30-day outcomes, therefore long-term outcomes could not be studied.

In conclusion, the current study identified high HbA1c levels and presence of trainees in the OR as potentially modifiable preoperative risk factors for adverse events following bariatric surgery in a nationally representative cohort. Improving preoperative glycemic control prior to bariatric surgery may be a feasible goal, which could represent an important quality improvement measure. Presence of trainees in the operating room, on the other hand, poses a more difficult challenge to overcome. Further studies focusing on surgical education would be warranted to implement safe and effective training in the field of bariatric surgery.

Funding None.

Disclosures Mr. Hart, Dr. Goffredo, Dr. Carroll, Dr. Lehmann, Dr. Nau, Dr. Smith, Dr. Ahad, Dr. Bao, and Dr. Hassan have no conflicts of interest or financial ties to disclose.

Changing trends in bariatric surgery

Trends in utilization of bariatric surgery, 2010-2014: sleeve gastrectomy dominates

Trends of bariatric surgery in France during the last 10 years: analysis of 267

Bariatric surgery implementation trends in the USA from

Surgery for Diabetes (2020) American society for metabolic and bariatric surgery

Effects of bariatric surgery on glycemic and lipid metabolism, surgical complication and quality of life in adolescents with obesity: a systematic review and meta-analysis

Bariatric surgery versus intensive medical therapy for diabetes -5-year outcomes

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

Type 1 diabetes mellitus and bariatric surgery: a systematic review and meta-analysis

The effectiveness of bariatric surgery for chinese obesity in 2 years: a meta-analysis and systematic review

Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity

Glucose regulation and cognitive function after bariatric surgery

Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis

Five-year outcomes of patients with type 2 diabetes who underwent laparoscopic adjustable gastric banding

Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year

Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes

Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries

The impact of preoperative testing for blood glucose concentration and haemoglobin A1c on mortality, changes in management and complications in noncardiac elective surgery: a systematic review

Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity

Practical guide to surgical data sets: metabolic and bariatric surgery accreditation and quality program (MBSAQIP)

Older age confers a higher risk of 30-day morbidity and mortality following laparoscopic bariatric surgery: an analysis of the metabolic and bariatric surgery quality improvement program

Perioperative safety in the longitudinal assessment of bariatric surgery

A novel risk prediction model for 30-day severe adverse events and readmissions following bariatric surgery based on the MBSAQIP database

Effect of elevated hemoglobin A1c in diabetic patients on complication rates after Roux-en-Y gastric bypass

High preoperative hemoglobin A1c is a risk factor for surgical site infection after posterior thoracic and lumbar spinal instrumentation surgery

Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery

Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures

Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery

The educating enigma: Does training level impact postoperative outcome in bariatric surgery

A challenge between trainee education and patient safety: does fellow participation impact postoperative outcomes following bariatric surgery?

Laparoscopic Roux-en-Y gastric bypass: differences in outcome between attendings and assistants of different training backgrounds

Impact of minimally invasive/ bariatric surgery fellowship on perioperative complications and outcomes in the first year of practice

Impact of bariatric fellowship training on perioperative outcomes for laparoscopic Roux-en-Y gastric bypass in the first year as consultant surgeon

Impact of fellowship training on the learning curve for laparoscopic gastric bypass